Increasing pressure is coming from the German public-sector healthinsurance funds for the government to approve the setting-up of a direct distribution service for drug products, along the lines of existing services in the Netherlands and the UK.
The reason for this pressure is the dramatic increase in pharmaceutical expenditures. Fund sources have said they estimate that the postal distribution of chronic-disease medications could save up to 600 million Deutschemarks ($295.5 million) annually in the medium term.
Ingo Kailuweit, the head of the KKH fund, has said that, so far, Health Minister Ulla Schmidt has shown that she has a "big heart" for the drug industry because her latest drug economies package will impact only one third of the spending growth that needs to be curtailed.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze